Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Longitudinal analysis of CYFRA 21-1 levels in patients with pulmonary nodules: Differential trajectories between benign and malignant cases.

PloS one·2026
Same author

Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules.

Annals of surgery·2026
Same author

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

A miniature magnetic switch unlocking multimodal, chip-free, and batteryless airway sensing.

Science advances·2026
Same author

Longitudinal Analysis of CYFRA 21-1 Levels in Patients with Pulmonary Nodules: Differential Trajectories Between Benign and Malignant Cases and Impact of Tumor Resection.

medRxiv : the preprint server for health sciences·2026
Same author

Sustained breath-holds in bronchoscopy: a pause worth taking?-a narrative review.

Journal of thoracic disease·2025

相关实验视频

Updated: May 5, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.1K

为生物异质癌症优化生物标志物模型:为肺癌进行嵌套模型方法.

Palina Woodhouse1, Laurel Jackson2, Michael N Kammer1

  • 1Vanderbilt University Medical Center, Nashville, Tennessee.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
|March 12, 2025
PubMed
概括

这项研究引入了一个嵌套的生物标志物模型,通过考虑癌症亚型异质性来改善早期肺癌检测. 该模型显示了更有效的多种癌症早期检测策略的前景.

更多相关视频

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

13.5K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

相关实验视频

Last Updated: May 5, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.1K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

13.5K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

科学领域:

  • 在瘤学瘤学.
  • 生物标志物发现发现
  • 癌症亚型 癌症亚型

背景情况:

  • 癌症亚型,特别是肺癌,表现出异质的生物学,使生物标志物的发展复杂化.
  • 传统模型难以整合多样化的组织学亚型,因为它们具有独特的生物特征.
  • 早期肺癌检测受到这种异质性的挑战.

研究的目的:

  • 探索一个嵌套的生物标志物模型,以解决癌症亚型异质性的问题.
  • 通过先进的建模,提高早期肺癌检测的准确性.
  • 加强多种癌症早期检测策略.

主要方法:

  • 在两个临床场所对337名患者的血液生物标志物的分析.
  • 开发一个嵌套的生物标志物模型,考虑组织学亚型异质性.
  • 嵌套模型与传统的物流回归和梅奥诊所模型的比较.

主要成果:

  • 嵌套模型的整体性能与现有模型相比较 (AUC 77.6训练,77.3测试).
  • 嵌套亚型与良性模型相比,表现优越,特别是在小细胞肺癌预测方面.
  • 患者队列包括各种恶性和良性结节,反映了现实世界肺癌的异质性.

结论:

  • 嵌套生物标志物模型显示了改善生物多样性癌症早期癌症检测的潜力.
  • 解决癌症异质性对于有效的生物标志物开发至关重要.
  • 需要在更大的队列中进一步验证,以确认这种方法的预测效益.